Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Cytarabine-anthracycline based intensive induction chemotherapy (IC) remains the standard of care for remission induction among fit patients with newly diagnosed acute myeloid leukemia (AML) in the United States (US). However, the mortality rate outside of clinical IC trials, predictors of death, an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Zeidan, Amer M., Podoltsev, Nikolai A., Wang, Xiaoyi, Zhang, Chi, Bewersdorf, Jan Philipp, Shallis, Rory M., Huntington, Scott F., Neparidze, Natalia, Giri, Smith, Gore, Steven D., Davidoff, Amy J., Ma, Xiaomei, Wang, Rong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189301/
https://ncbi.nlm.nih.gov/pubmed/32311013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados